Summary A long term follow-up study has been undertaken in 33 patients with acute non-lymphoblastic leukaemia (ANLL) in order to establish whether a correlation exists between the clinical course and the immunologic pattern of lymphoid subpopulations. Peripheral blood lymphoid cells have been investigated longitudinally (each 1 to 4 months) during complete remission (CR), by morphologic, phenotypic and functional analyses. Particular attention has been paid to the evaluation of the natural killer (NK) cell compartment, by the detection of cells expressing an NK-related phenotype and by NK in vitro assay. Among the patients so far evaluable, 20 relapsed (R) and 10 are long survivors in CR 'off therapy' (LS). The most relevant finding was represented by statistically higher values of NK activity observed in LS vs. R patients (P<0.01). The removal of adherent cells before the NK assay, performed to investigate the possible inhibitory effect on NK function played by the macrophage component, abolished this difference, due to a selective increase of NK function in the R group. The longitudinal study revealed that NK activity tended to decrease in individual patients who subsequently relapsed. These data suggest a possible role of NK cells in the relapse control of ANLL, although it cannot be excluded that the low level of NK activity observed in the R group is the result of impending relapse rather than its cause.
Recent advances in the treatment of acute non-lymphoblastic leukaemia (ANLL) led to a substantial increase in the number of patients who experience prolonged complete remissions (CR) which may -end in a cure of the disease in a proportion of cases (Champlin et al., 1985) . The best results seem to be obtained in patients submitted to allogeneic bone marrow transplantation (BMT) (Dinsmore et al., 1984; Gale & Champlin, 1986) . Unfortunately, less than 10% of ANLL patients can take advantage of this procedure for a number of reasons, including the lack of compatible donors, age over 40, and complications related to the transplant (Gale & Champlin, 1986) . Despite therapeutic improvements, the overall results seem to indicate that a relapse still occurs within 18 months from the achievement of CR in the majority of patients with ANLL (Champlin et al., 1985; Rees et al., 1986) . A number of prognostic factors, possibly independent of treatment, have been suggested to be associated with the duration of CR (reviewed by Gale & Foon, 1986) . Some of them are likely to be related to intrinsic biological properties of the leukaemic cells, such as cellular lineage, kinetic parameters, chromosome abnormalities, enzymatic pattern, etc. Other prognostic factors seem to be more connected with the host, including sex, age, and immunologic reactivity. In particular, the last of these could play a role in controlling the proliferation of the residual leukaemic cells eluding the treatment and eventually responsible for the relapse. Beside some experimental evidence (Cheever et al., 1980 ; Karre et al., 1980) , the possibility of such an immunologic control mechanism is also supported by a number of clinical reports. Among them, the beneficial effect of viral hepatitis in ANLL (Barton & Conrad, 1979; Rotoli et al., 1982) , and the apparent anti-leukaemia effect of graft-versushost-disease (GvHD) following allogeneic BMT (Weiden et al., 1979; Bacigalupo et al., 1985) . Both these conditions are characterised by major alterations of the phenotypic and functional profiles of the reactive lymphoid cells, including those accounting for cytotoxic mechanisms (Chemello et al., 1986; Dienstag & Bhan, 1980; Lopez et al., 1979) .
In this paper we investigated the correlations between the clinical course of ANLL and the immunologic pattern of their lymphoid subpopulations, in order to look for indirect evidence of a possible mechanism which might be involved in the control of relapse. For this purpose, peripheral blood mononuclear cells (PBMC) of 33 patients with ANLL in their first CR were longitudinally evaluated by morphologic, phenotypic, and functional approaches. Particular attention was paid to the analysis of the natural killer (NK) cell compartment, since it is believed to represent the first-line of defence against the spread of tumour cells (Herberman, 1983 ).
Patients and methods

Patients
Thirty-three patients (15 males, 18 females; mean age 37, range 14-67 years) were studied, from March 1983 to June 1987, during their first CR. All of them had a diagnosis of ANLL made in our institution between January 1978 and December 1986 on the basis of standard criteria, according to the French-American-British (FAB) classification system (Bennett et al., 1976) . All patients received a similar treatment based on a standard induction therapy with 3 to 4 courses of adriamycin, thioguanine and cytosine arabinoside, and on a maintenance therapy with COAP regimen (Whitecar et al., 1972) 
Phenotypic analysis
Cell suspensions from PBMC were obtained by FicollHypaque gradient separation from freshly drawn heparinised blood and incubated with fluorochrome-conjugated monoclonal antibodies. These included OKT11 (CD2) (from Ortho Pharmaceutical, Raritan, NJ), Leu3 (CD4), Leu2 (CD8), Leu7, and Leul 1 (CD16) (from Becton-Dickinson, Sunnyvale, CA). OKT1I binds the sheep erythrocyte receptor (Reinherz et al., 1980) ; Leu3 and Leu2 react with the two lymphocyte subsets which include helper and cytotoxic/ suppressor cells, respectively (Reinherz et al., 1980) ; Leu7 and Leull react with antigens related to the NK compartment (Lanier et al., 1983) . The evaluation was made with a fluorescence microscope on 300 cells per sample.
NK cell activity NK activity was assessed by evaluating the lysis of 51Cr-labelled K-562 target cells (Semenzato et al., 1986) . Briefly, I x 106 target cells were labelled overnight at 37°C in 5% CO2 atmosphere with 100 pCi Na2(5"Cr)O4 (CIA IRE Sorin, Biomedica, Saluggia, Italy) and extensively washed before use. Cells (1 x 104) were resuspended in each well of a Vshaped plate (Titertech, Falcon Lab.) and graded concentrations of PBMC were added to wells in triplicate and incubated for 4 h at 37°C in 5% CO2. Following this incubation, supernatants were harvested and counted in a gamma counter. The mean value of triplicate assays was used to calculate the percentage of cytotoxicity, as already reported. The analysis of NK activity was performed comparing the values of cytotoxicity in the different groups at an effector/target (E/T) ratio of 40:1. In 74% of determinations NK activity was carried out simultaneously on unfractionated PBMC and after removal of monocytes by adherence to plastic dishes, as previously reported in detail (Semenzato et al., 1986 NK cell activity The overall results of NK activity detected on PBMC nonmonocyte-depleted at E/T ratio of 40:1 are reported in Table II . The figures were higher in LS as compared to R (P <0.01). However, the LS values were not statistically different from controls. The analysis of individual values indicates that determinations below the interval of normality were 18% in LS as compared to 57% in R. On the other hand, the determinations exceeding the control range were 31% in LS, and 5% in R. Monocyte depletion by the removal of adherent cells reduced the differences in terms of NK activity observed between LS and R on PBMC 'nondepleted' (Table II) . This was mainly due to an increase of The data on NK cell activity analysed in individual patients showed a more composite pattern. In LS, 4 out of 10 patients had values consistently exceeding the range of controls (Figure 1 Our study indicates that long surviving patients with ANLL in CR exhibit higher in vitro NK activity of PBMC, associated with increased levels of NK-related cells (LGL and Leu 11+), as compared to patients who subsequently relapsed. Other major phenotypic differences were not observed between the two groups. These data suggest a possible role of NK cells in the relapse control of ANLL. However, this suggestion has to be considered with caution, since the study is also open to other plausible interpretations. First, the differences observed between the two groups could be related to the effect of therapy. In fact, 79% of determinations were performed during maintenance therapy in the R group, as opposed to 19% in LS. Although it is possible that therapy might have influenced some parameters, a number of considerations suggest that the differences observed in terms of NK function and/or inhibition of NK activity by adherent cells, may not be merely attributable to therapy. The therapy-related depression of NK function previously reported in patients with acute leukaemia (Fontana et al., 1984; McGeorge et al., 1982) was shown to be confined to the period of treatment, with recovery of NK activity within days after therapy ceased (McGeorge et al., 1982) . In all patients investigated during maintenance ther- Figure 1 ). In addition, the decrease of NK values observed during the last months of CR in 10 out of 20 patients who subsequently relapsed occurred with no variation of therapy (see Figure 1 , representative cases 3 and 4). The above considerations taken together, suggest that a possible influence of therapy on the NK system is unlikely to represent the major cause of the difference we observed in the patient groups.
Although it cannot be excluded on the basis of our data that the low level of NK activity observed in the R group is the result of relapse rather than its cause, the alternative and more exciting possibility indirectly suggested by our findings is that a causative relationship exists between NK cell activity and control of relapse, the former being higher in patients who experienced longest survivals. This would be in line with the well known capability of NK cells to inhibit the in vitro growth of fresh clonogenic leukaemic cells (Beran et al., 1983; Lotzova, 1985) . If this is the case, a number of possible mechanisms could be considered, which in vivo may play a role in the control of the relapse, through a positive or negative balance of NK function. These mechanisms could be related either to the host or to the residual leukaemic cells. Viral hepatitis has been shown to be associated with prolonged survivals in ANLL (Barton & Conrad, 1979; Rotoli et al., 1982) . Such an anti-leukaemia effect could be related to the enhanced cytotoxic capability, which is present on PBMC in these conditions (Chemello et al., 1986; Dienstag & Bhan, 1980) . Interestingly, viral hepatitis occurred in 8 out of 10 LS patients (type B 7 cases; non-A, non-B 1 case), as opposed to 3 out of 20 cases observed in R. Thus, the higher incidence of viral hepatitis which occurred in LS group could be correlated with the higher NK cell activity observed in these patients who experienced the longest survival.
The observed inhibitory effect on NK cell function preferentially exerted by adherent cells on patients in the R group, might also be of relevance as a negative factor in control of leukaemia. The explanation for the greater inhibitory capability observed in R patients as compared to LS is not simply attributable to a quantitative difference of the monocyte number between the two groups (R vs. LS = NS). The stronger inhibition in R patients could be related to intrinsic functional aspects of their monocyte component, possibly through a mechanism involving the production of prostaglandins which are capable of inhibiting NK function (Brunda et al., 1980; Combe et al., 1984; Hall et al., 1983) . Since the R group includes a large proportion of cases (11 out of 20) with M4 morphology, it is tempting to speculate on the possible role of the residual leukaemic component as the effector of NK inhibition. This leukaemic component could well be undetectable as a blast cell population, since normal-looking mature cells can belong to the leukaemic progeny (Fearon et al., 1986) . A negative influence on disease control via inhibition of the NK system mediated by functionally active residual leukaemic cells belonging to the monocyte lineage would represent an interesting, if hypothetical, explanation of the well known high relapse rate in acute monycytic leukaemia (Appelbaum et al., 1984) .
In conclusion, our data seem to support the possibility that NK cells play a role in the control of relapse in ANLL. However, this suggestion needs to be supported by further studies on patient cytotoxic activity against autologous active phase and relapse leukemia cells.
